U.S. Sleep Therapy Market Driven by Growing Population Diagnosed with Sleep Apnea: Led By Philips Respironics, ResMed and Fisher & Paykel

As awareness of the risks and early warning signs of sleep apnea increase, more patients are expected to seek medical treatment, leading to an increase of patients diagnosed and treated with obstructive sleep apnea, reports iData Research

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
It is estimated that 70% to 85% of patients that are diagnosed with sleep apnea are recommended some form of (PAP) treatment

Vancouver, BC (PRWEB) September 03, 2014

According to a report by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the U.S. anesthesia, respiratory and sleep-management device market will reach approximately $4 billion by 2019, with strong growth being driven by the sleep therapy devices market. This market accounts for just over a third of the overall market and includes positive airway pressure (PAP) therapeutic machines and sleep therapy interfaces.

The sleep therapy market will be driven by the growing awareness among the general population of both the symptoms of sleep apnea and the potential dangers associated with leaving the condition untreated. There are three types of sleep apnea cases: obstructive sleep apnea (OSA), central sleep apnea (CSA) and complex sleep apnea, which happens when the apneic events are caused by a combination of OSA and CSA factors. The most common form of sleep apnea is OSA, which accounts for approximately 80% of all sleep apnea cases.

There are numerous treatments available for sufferers of obstructive sleep apnea. The simplest of these treatments involve changes in lifestyle, including weight loss, avoiding respiratory depressants such as alcohol and/or smoking. “It is estimated that 70% to 85% of patients that are diagnosed with sleep apnea are recommended some form of (PAP) treatment,” says Dr. Kamran Zamanian, CEO of iData. PAP machines are flow generators that force air into the laryngeal cavity via a mask that a patient wears as they sleep.

Competitors leading this market include Philips Respironics, Fisher & Paykel and ResMed with their easy breathe waveform, which intelligently recreates a patient’s breathing patterns. Within the sleep therapy industry, low patient compliance to traditional techniques has been the most significant driver of new research and development. Companies have been quick to introduce new features, such as new designs, gel or silicone cushions or customized fittings meant to address individual patient needs and increase the comfort of the patient while using a PAP device.

For More Information
The report for U.S. anesthesia, respiratory and sleep-management device market include anesthesia delivery units (ADUs), anesthesia patient monitors, anesthesia information management systems (AIMS), anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy devices, therapeutic obstructive sleep apnea devices and sleep diagnostic devices.

Request a complimentary synopsis from the report

About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.


Contact

Follow us on: Contact's Google Plus